Delivery Order SPE2DB24D3014-SPE2DB25FKTFL
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $14,301.55 to AmerisourceBergen Drug Corp on May 8, 2025, for the supply of Vaxneuvance 0.5 ML syringes. The contract utilizes firm fixed pricing with no set-aside designation, indicating competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical procurement needs, particularly for military and veteran healthcare systems. The...
- The Defense Logistics Agency awarded a delivery order valued at $46,657.70 to AmerisourceBergen Drug Corp for the supply of Vaxneuvance 0.5 ML syringes on September 15, 2025, with completion scheduled for September 16, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Vaxneuvance 0.5 mL syringes valued at $20,502.36. This firm fixed-price delivery order, which is set to conclude on September 11, 2025, will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The contract was competitively awarded without set-aside designation, reflecting AmerisourceBergen's established capability to meet federal...
- The Defense Logistics Agency awarded a $13,703.90 delivery order to AmerisourceBergen Drug Corp on June 16, 2025, for the supply of Vaxneuvance 0.5 mL syringes. This is a firm fixed price, competitively awarded contract with an ultimate completion date of June 17, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The award carries no set-aside designation, reflecting open competition among qualified vendors. This delivery order is issued under...
- The Defense Logistics Agency awarded a $1,791.63 delivery order to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of Vaxneuvance 0.5 mL syringes. This firm fixed-price contract, which is not set-aside, is scheduled for completion by September 19, 2025, with performance taking place at the contractor's Corporate Office location in Conshohocken, Pennsylvania. The award represents a single delivery transaction under AmerisourceBergen's existing pharmaceutical supply framework...
- The Defense Logistics Agency awarded a $17,804.46 delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Vaxneuvance 0.5 mL syringes. This is a firm fixed price, competitively awarded contract with an ultimate completion date of July 22, 2025, and will be performed in Conshohocken, Pennsylvania. The contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 prime...
- The Defense Logistics Agency awarded a $6,121.40 delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Vaxneuvance 0.5 ML syringes. This competitive, non-set-aside contract represents a firm fixed price delivery order with an ultimate completion date of August 13, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that...
- The Defense Logistics Agency awarded a delivery order valued at $48,271.25 to AmerisourceBergen Drug Corp for the supply of Vaxneuvance 0.5 ML syringes, with a completion date of September 16, 2025. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award. The contract will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters as a major pharmaceutical distributor and...
- The Defense Logistics Agency awarded a delivery order valued at $2,740.70 to AmerisourceBergen Drug Corp for the supply of Vaxneuvance 0.5 mL syringes on August 19, 2025, with an ultimate completion date of August 20, 2025. This contract utilized firm fixed price pricing and was competitively awarded without any set-aside designation. The product will be delivered to AmerisourceBergen's location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Vaxneuvance 0.5 ML syringes, with a contract ceiling value of $2,740.78. The award was issued on July 31, 2025, with an ultimate completion date of August 1, 2025. This is a firm fixed-price delivery order with no set-aside designation, indicating the contract was competitively awarded. The place of performance is listed as Conshohocken, Pennsylvania, which is also the location of...
- SPE2DB24D3014Indefinite Delivery Contract
- SPE2DB24D3014-SPE2DB25FKTFLDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $4,064.07 to AmerisourceBergen Drug Corp for the supply of Vaxneuvance 0.5 ml syringes, with completion targeted for April 24, 2025. This contract represents a firm fixed price delivery order with no set-aside designation, indicating competitive award through open procurement. The product will be delivered to the contractor's location in Conshohocken, Pennsylvania. This delivery order is a child contract under AmerisourceBergen Drug Corp's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. This comprehensive prime vendor agreement enables AmerisourceBergen to supply a broad range of pharmaceutical products, vaccines, and medical supplies to support military healthcare programs globally, including services to the Defense Health Agency and U.S. Coast Guard. The firm is a major pharmaceutical distributor headquartered in Conshohocken and serves as a critical federal medical procurement vendor, with its federal contract portfolio demonstrating extensive experience fulfilling diverse pharmaceutical and medical supply requirements across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.1k | 4/23/25 |